De ce aleg tot mai mulți pacienți occidentali China în locul SUA pentru noi tratamente împotriva cancerului. Terapia care costă o avere în America, la jumătate de preț la Shanghai

More Western patients are choosing China for cancer treatments due to lower costs and advancements in biotechnology. CAR-T therapy, initially developed in the U.S., is now more affordable in Shanghai, attracting patients like Michael Walters and Josh Bronkhorst. They found successful treatment options at a fraction of U.S. prices, with CAR-T therapies costing between $150,000 and $230,000 in China compared to $550,000 to $850,000 in the U.S. Despite some controversies regarding clinical trial transparency, China's rapid innovation in cancer treatment is evident, with multiple CAR-T therapies approved for various cancers. The trend indicates a shift in global healthcare dynamics, as more patients seek effective and affordable options abroad.